GLEAX | SPMVX | GLEAX / SPMVX | |
Total Expense Ratio | 1.48 | 9.93 | 15% |
Annual Report Gross Expense Ratio | 1.54 | 9.93 | 16% |
Fund Existence | 8 years | 6 years | - |
Gain YTD | 3.809 | 5.993 | 64% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 452M | 2.05B | 22% |
Annual Yield % from dividends | 2.76 | 5.80 | 48% |
Returns for 1 year | 5.83 | 17.02 | 34% |
Returns for 3 years | 39.57 | 76.82 | 52% |
Returns for 5 years | 139.76 | 246.25 | 57% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GIDAX | 8.34 | N/A | N/A |
Goldman Sachs Intl Eq Div & Prem A | |||
PHPIX | 27.39 | N/A | N/A |
ProFunds Pharmaceuticals UltraSector Inv | |||
BISAX | 25.66 | N/A | N/A |
Brandes International Small Cap Equity A | |||
ANORX | 20.24 | N/A | N/A |
American Century Small Cap Growth R | |||
TVAFX | 80.80 | -0.01 | -0.01% |
Thornburg Small/Mid Cap Core A |